Valganciclovir for the Prevention of CMV After Treatment of Rejection with Anti-Lymphocyte Depleting Antibodies in Kidney Transplant Recipients.

M. Mahoney,J. Nelson, E. Kincaide,R. Hall, H. Sweiss

AMERICAN JOURNAL OF TRANSPLANTATION(2022)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要